Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)
[Report Updated: 23-09-2016]


Related Topics: Boehringer Ingelheim , FDA

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Pharmacovigilance
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse reactions. Globally, increasing incidence rates of ADR (adverse drug reaction) which also represent a substantial burden on healthcare systems, coupled with the introduction of stringent government policies in developing nations pertaining to drug safety regulations are some key factors expected to drive the pharmacovigilance market during the period of study.


Geographically, North America dominated the pharmacovigilance market driven by strict drug safety approval regulations imposed by the U.S. FDA and other regulatory authorities coupled with increasing pressure for maintaining electronic medical records (EMR). North America was followed by Europe and Asia-Pacific as second and third largest market for the pharmacovigilance market. Asia Pacific is projected to have the fastest growth, owing to availability of large pool of educated and cost-effective labor force, the presence of favorable business environment and the implementation of government initiatives aimed at improving healthcare access in developing nations such as India and China.

This report identifies the pharmacovigilance market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the pharmacovigilance market.

This report segments the pharmacovigilance market on the basis of clinical trial phase, type of service provider and regional market as follows:

Pharmacovigilance market research report is classified on the basis of clinical trial phase. Some of the major clinical trial phases covered in this report are as follows: Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial

Pharmacovigilance market research report is classified on the basis of type of service provider. Some of the major service provider types covered in this report are as follows: In House, Contract Outsourcing

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the pharmacovigilance market. Some of the major companies’ profiles in detail are as follows:

Quintiles Transnational Corporation

Accenture Plc.

Boehringer Ingelheim GmbH

Bristol-Myers Squibb

PAREXEL International Corporation

Table of Contents
for Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022) [Report Updated: 23-09-2016]

  • 1. Pharmacovigilance Market – Overview

    2. Executive Summary

    3. Pharmacovigilance Market Landscape

    3.1. Market Share Analysis

    3.2. Comparative Analysis

    3.3. Product Benchmarking

    3.4. End User Profiling

    3.5. Top 5 Financials Analysis

    4. Pharmacovigilance Market– Forces

    4.1. Drivers

    4.1.1. Strict drug regulations in developed nations

    4.2. Restraints

    4.3. Opportunities

    4.4. Challenges

    4.5. Porter’s Five Forces Analysis

    4.5.1. Bargaining Power of Suppliers

    4.5.2. Bargaining Power of Buyers

    4.5.3. Threat of New Entrants

    4.5.4. Threat of Substitutes

    4.5.5. Degree of Competition

    5. Pharmacovigilance Market– Strategic Analysis

    5.1. Value Chain Analysis

    5.2. Pricing Analysis

    5.3. Opportunities Analysis

    5.4. Product/Market Life Cycle Analysis

    5.5. Suppliers and Distributors

    6. Pharmacovigilance Market, By Clinical Trial Phase

    6.1. Preclinical Studies

    6.2. Phase I/1

    6.3. Phase II/2

    6.4. Phase III/3

    6.5. Phase IV/4 Trial

    7. Pharmacovigilance Market, By Type of Service Provider

    7.1. In House

    7.2. Contract Outsourcing

    8. Pharmacovigilance Market, By Geography

    8.1. Europe

    8.1.1. Germany

    8.1.2. France

    8.1.3. Italy

    8.1.4. Spain

    8.1.5. Russia

    8.1.6. U.K.

    8.1.7. Rest of Europe

    8.2. Asia Pacific

    8.2.1. China

    8.2.2. India

    8.2.3. Japan

    8.2.4. South Korea

    8.2.5. Rest of Asia-Pacific

    8.3. North America

    8.3.1. U.S.

    8.3.2. Canada

    8.3.3. Mexico

    8.4. Rest of the World (RoW)

    8.4.1. Brazil

    8.4.2. Rest of RoW

    9. Pharmacovigilance Market – Entropy

    9.1. Expansion

    9.2. Technological Developments

    9.3. Merger & Acquisitions, and Joint Ventures

    9.4. Supply- Contract

    10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

    10.1. Quintiles Transnational Corporation

    10.2. Accenture Plc.

    10.3. Boehringer Ingelheim GmbH

    10.4. Bristol-Myers Squibb

    10.5. PAREXEL International Corporation

    10.6. Janssen Research & Development, LLC

    10.7. Pharmaceutical Product Development, Inc.

    10.8. United BioSource Corporation

    10.9. Synowlwedge LLC

    10.10. Cognizant Technology Solutions Corporation

    10.11. Covance Inc.

    10.12. ICON, Plc

    *More than 40 Companies are profiled in this Research Report, Complete List available on Request*

    "*Financials would be provided on a best efforts basis for private companies"

    11. Appendix

    11.1. Abbreviations

    11.2. Sources

    11.3. Research Methodology

    11.4. Bibliography

    11.5. Compilation of Expert Insights

    11.6. Disclaimer

List Of Tables
in Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022) [Report Updated: 23-09-2016]

No

Additional Details

Publisher

Publisher Information

Reference

80600 | HCR 0401

Report Format

PDF

 Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Pharmacovigilance Software-Global Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-Global Market Status and Trend Report 2013-2023 offers a co...
08 Jan 2018 by MIReports USD $2,108 (normally
USD $2,480)
More Info
SAVE 15% today! Pharmacovigilance Software-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report SummaryPharmacovigilance Software-Global Market Status & Trend Report 2013-2023 Top 20 Countr...
08 Jan 2018 by MIReports USD $3,128 (normally
USD $3,680)
More Info
SAVE 15% today! Pharmacovigilance Software-North America Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-North America Market Status and Trend Report 2013-2023 offe...
08 Jan 2018 by MIReports USD $2,958 (normally
USD $3,480)
More Info
SAVE 15% today! Pharmacovigilance Software-South America Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-South America Market Status and Trend Report 2013-2023 offe...
08 Jan 2018 by MIReports USD $2,958 (normally
USD $3,480)
More Info
SAVE 15% today! Pharmacovigilance Software-Europe Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-Europe Market Status and Trend Report 2013-2023 offers a co...
08 Jan 2018 by MIReports USD $2,958 (normally
USD $3,480)
More Info
SAVE 15% today! Pharmacovigilance Software-EMEA Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-EMEA Market Status and Trend Report 2013-2023 offers a comp...
08 Jan 2018 by MIReports USD $2,958 (normally
USD $3,480)
More Info
SAVE 15% today! Pharmacovigilance Software-Asia Pacific Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-Asia Pacific Market Status and Trend Report 2013-2023 offer...
08 Jan 2018 by MIReports USD $2,958 (normally
USD $3,480)
More Info
SAVE 15% today! Global and Chinese Pharmacovigilance Drug Safety Software Industry, 2017 Market Research Report
The 'Global and Chinese Pharmacovigilance Drug Safety Software Industry, 2012-2022 Market Research R...
23 Dec 2017 by Prof Research USD $2,550 (normally
USD $3,000)
More Info
SAVE 15% today! Pharmacovigilance Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2020
Future Market Insights offers a 6-year forecast of the global pharmacovigilance market between 2015 ...
04 Dec 2015 by Future Market Insights USD $4,250 (normally
USD $5,000)
More Info
SAVE 15% today! Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019
The global pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.5% f...
26 Mar 2015 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info

We Stock...